- New Purchases: SYK, RPRX, 02269,
- Added Positions: REGN, EW, DHR, PFE, TMO, A, BSX, BIIB, ISRG, TFX, 4568, NVST, 4503, 4543, HOLX, BLUE, MYL,
- Reduced Positions: LLY, VRTX, 4519, MRK, MDT, ZBH, SGEN, BMY, ELAN, MOH, UCB, CNC, ALNY, ROG, 6869, 4502, ILMN, ARGX,
- Sold Out: QGEN, PTLA, CTEC,
For the details of Vanguard Health Care Fund's stock buys and sells, go to https://www.gurufocus.com/guru/vanguard+health+care+fund/current-portfolio/portfolio
These are the top 5 holdings of Vanguard Health Care Fund- UnitedHealth Group Inc (UNH) - 9,095,277 shares, 5.82% of the total portfolio.
- AstraZeneca PLC (AZN) - 24,437,364 shares, 5.52% of the total portfolio.
- Pfizer Inc (PFE) - 72,260,247 shares, 5.13% of the total portfolio. Shares added by 12.70%
- Bristol-Myers Squibb Company (BMY) - 35,181,964 shares, 4.49% of the total portfolio. Shares reduced by 5.22%
- Novartis AG (NOVN) - 19,912,128 shares, 3.76% of the total portfolio.
Vanguard Health Care Fund initiated holding in Stryker Corp. The purchase prices were between $144.67 and $207.03, with an estimated average price of $184.16. The stock is now traded at around $200.55. The impact to a portfolio due to this purchase was 0.42%. The holding were 1,079,241 shares as of .
New Purchase: Royalty Pharma PLC (RPRX)Vanguard Health Care Fund initiated holding in Royalty Pharma PLC. The purchase prices were between $44.5 and $52.11, with an estimated average price of $49.5. The stock is now traded at around $42.78. The impact to a portfolio due to this purchase was 0.32%. The holding were 3,053,455 shares as of .
New Purchase: WuXi Biologics (Cayman) Inc (02269)Vanguard Health Care Fund initiated holding in WuXi Biologics (Cayman) Inc. The purchase prices were between $100.5 and $149.5, with an estimated average price of $125.63. The stock is now traded at around $159.50. The impact to a portfolio due to this purchase was 0.25%. The holding were 6,344,000 shares as of .
Added: Regeneron Pharmaceuticals Inc (REGN)Vanguard Health Care Fund added to a holding in Regeneron Pharmaceuticals Inc by 42.78%. The purchase prices were between $488.29 and $643.92, with an estimated average price of $565.62. The stock is now traded at around $631.47. The impact to a portfolio due to this purchase was 1.04%. The holding were 2,556,310 shares as of .
Added: Edwards Lifesciences Corp (EW)Vanguard Health Care Fund added to a holding in Edwards Lifesciences Corp by 235.29%. The purchase prices were between $57.54 and $76.95, with an estimated average price of $70.98. The stock is now traded at around $78.95. The impact to a portfolio due to this purchase was 0.99%. The holding were 9,400,502 shares as of .
Added: Danaher Corp (DHR)Vanguard Health Care Fund added to a holding in Danaher Corp by 71.39%. The purchase prices were between $128.7 and $176.83, with an estimated average price of $161.23. The stock is now traded at around $202.10. The impact to a portfolio due to this purchase was 0.9%. The holding were 5,640,599 shares as of .
Added: Thermo Fisher Scientific Inc (TMO)Vanguard Health Care Fund added to a holding in Thermo Fisher Scientific Inc by 26.26%. The purchase prices were between $275.2 and $362.34, with an estimated average price of $334.21. The stock is now traded at around $410.56. The impact to a portfolio due to this purchase was 0.55%. The holding were 3,347,387 shares as of .
Added: Agilent Technologies Inc (A)Vanguard Health Care Fund added to a holding in Agilent Technologies Inc by 245.37%. The purchase prices were between $68.92 and $91.14, with an estimated average price of $81.76. The stock is now traded at around $95.94. The impact to a portfolio due to this purchase was 0.41%. The holding were 3,049,141 shares as of .
Added: Intuitive Surgical Inc (ISRG)Vanguard Health Care Fund added to a holding in Intuitive Surgical Inc by 257.31%. The purchase prices were between $458.26 and $592.76, with an estimated average price of $536.99. The stock is now traded at around $687.39. The impact to a portfolio due to this purchase was 0.26%. The holding were 291,269 shares as of .
Sold Out: Qiagen NV (QGEN)Vanguard Health Care Fund sold out a holding in Qiagen NV. The sale prices were between $39.49 and $44.36, with an estimated average price of $42.17.
Sold Out: Portola Pharmaceuticals Inc (PTLA)Vanguard Health Care Fund sold out a holding in Portola Pharmaceuticals Inc. The sale prices were between $6.41 and $17.99, with an estimated average price of $13.76.
Sold Out: ConvaTec Group PLC (CTEC)Vanguard Health Care Fund sold out a holding in ConvaTec Group PLC. The sale prices were between $1.78 and $2.19, with an estimated average price of $1.99.
Reduced: Eli Lilly and Co (LLY)Vanguard Health Care Fund reduced to a holding in Eli Lilly and Co by 22.16%. The sale prices were between $136.42 and $164.18, with an estimated average price of $153.12. The stock is now traded at around $153.00. The impact to a portfolio due to this sale was -1.05%. Vanguard Health Care Fund still held 10,526,547 shares as of .
Reduced: Vertex Pharmaceuticals Inc (VRTX)Vanguard Health Care Fund reduced to a holding in Vertex Pharmaceuticals Inc by 27.52%. The sale prices were between $225.48 and $295.8, with an estimated average price of $270.45. The stock is now traded at around $279.40. The impact to a portfolio due to this sale was -0.76%. Vanguard Health Care Fund still held 3,342,220 shares as of .
Reduced: Chugai Pharmaceutical Co Ltd (4519)Vanguard Health Care Fund reduced to a holding in Chugai Pharmaceutical Co Ltd by 25.65%. The sale prices were between $4025 and $5821.67, with an estimated average price of $4818.65. The stock is now traded at around $4968.00. The impact to a portfolio due to this sale was -0.67%. Vanguard Health Care Fund still held 20,021,400 shares as of .
Reduced: Merck & Co Inc (MRK)Vanguard Health Care Fund reduced to a holding in Merck & Co Inc by 34.54%. The sale prices were between $73.8 and $83.98, with an estimated average price of $78.88. The stock is now traded at around $79.07. The impact to a portfolio due to this sale was -0.59%. Vanguard Health Care Fund still held 5,732,246 shares as of .
Reduced: Zimmer Biomet Holdings Inc (ZBH)Vanguard Health Care Fund reduced to a holding in Zimmer Biomet Holdings Inc by 66.1%. The sale prices were between $89.63 and $137.4, with an estimated average price of $118.39. The stock is now traded at around $138.24. The impact to a portfolio due to this sale was -0.42%. Vanguard Health Care Fund still held 836,580 shares as of .
Reduced: Seattle Genetics Inc (SGEN)Vanguard Health Care Fund reduced to a holding in Seattle Genetics Inc by 41.3%. The sale prices were between $111.24 and $171.13, with an estimated average price of $148.32. The stock is now traded at around $171.14. The impact to a portfolio due to this sale was -0.34%. Vanguard Health Care Fund still held 1,669,723 shares as of .
Here is the complete portfolio of Vanguard Health Care Fund. Also check out:
1. Vanguard Health Care Fund's Undervalued Stocks
2. Vanguard Health Care Fund's Top Growth Companies, and
3. Vanguard Health Care Fund's High Yield stocks
4. Stocks that Vanguard Health Care Fund keeps buying